ULF Neuromodulation System

About Presidio Medical

Presidio Medical is a private, clinical-stage medical device company pioneering a new approach to neuromodulation for chronic nociceptive pain. Its core technology, the Ultra Low Frequency (ULF™) Neuromodulation System, is designed to inhibit neuronal activity at the pain site, offering a potential therapeutic option for a large patient population underserved by current neuropathic pain-focused devices. Led by a seasoned management team with deep experience from companies like Boston Scientific, Abbott, and Alcon, the company is positioned to address a significant unmet need in the chronic pain market. Presidio is currently in the development and clinical validation stage, building its team and advancing its technology toward commercialization.

Therapeutic Areas